University of Minnesota. Driven to Discover.
Flu hospitalizations are also on the rise, with the highest levels in seniors, a pattern often seen in H3N2-dominant seasons.
The CDC said the H3N2-dominant trend will make neuraminidase inhibitor antivirals especially useful this flu season.
Coverage in adults over 50 increased, but immunization reached only 46.8% of the US population.
Experts ponder why FluMist performed poorly in the US but well elsewhere.
Vaccine effectiveness was 65% in preventing deaths in healthy children and 51% in high-risk kids.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.